Trial intelligence / Profile preview

PRP for Recurrent Intrauterine Adhesions

NCT03541746Completed

Sponsor
Ain Shams University Maternity Hospital
Start
Apr 2017
Primary completion
Jan 2018
Modality
Hydrogel Systems, Cell Therapies
Countries
1
01

Overview

Randomised trial of autologous platelet rich gel in Asherman's syndrome (AS) (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: Prevent recurrence of intrauterine adhesions at 1 month. Started Apr 2017; status: completed.

02

Drugs

autologous platelet rich gel
03

Conditions

Asherman's syndrome (AS)

Beyond the preview

Go deeper on NCT03541746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03541746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call